This article was originally published in The Tan Sheet
New Web-based system allows OTC drug, dietary supplement manufacturers to electronically submit new product labeling, labeling updates to the Physician's Desk Reference, publisher Thomson Medical Economics says June 4. Labeling submissions are reformatted as they will appear in the PDR and posted on a secure Web site for manufacturer review, final clearance. Approved entries will be available for electronic distribution through 1www.pdr.net and on CD-ROM, with print version appearing in annual editions of the PDR for Nonprescription Drugs & Dietary Supplements. Thomson developed PDRxpress with several drug companies and says system "eliminates weeks of paper processing"...
You may also be interested in...
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.